Nucleoside and Non-Nucleoside DOT1L Inhibitors: Dawn of MLL-rearranged Leukemia

Cao, M; Li, T; Chen, YX; Zhai, X

Zhai, X (corresponding author), Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China.

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021; 21 (11): 1337

Abstract

Herein, the underlying role of disruptor of telomeric silencing 1-like (DOT1L) as a therapeutic target for mixed-lineage leukemia (MLL)-rearranged is ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索